---
title: "Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors"
collection: publications
permalink: /publication/2021-12-01-Diffusion-MRI-is-an-early-biomarker-of-overall-survival-benefit-in-IDH-wild-type-recurrent-glioblastoma-treated-with-immune-checkpoint-inhibitors
date: 2021-12-01
venue: 'Neuro Oncol'
citation: ' A. Hagiwara,  T. Oughourlian,  N. Cho,  J. Schlossman,  C. Wang,  J. Yao,  C. Raymond,  R. Everson,  K. Patel,  S. Mareninov,  F. Rodriguez,  N. Salamon,  W. Pope,  P. Nghiemphu,  L. Liau,  R. Prins,  T. Cloughesy,  B. Ellingson, &quot;Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors.&quot; Neuro Oncol, 2021.'
---
Use [Google Scholar](https://scholar.google.com/scholar?q=Diffusion+MRI+is+an+early+biomarker+of+overall+survival+benefit+in+IDH+wild+type+recurrent+glioblastoma+treated+with+immune+checkpoint+inhibitors){:target="_blank"} for full citation